(Q45077756)

English

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

9 December 2017

steatohepatitis

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Sanjay K Satapathy

1

1 reference

Europe PubMed Central

9 December 2017

Sanjay Garg

2

1 reference

Europe PubMed Central

9 December 2017

Ranjeet Chauhan

3

1 reference

Europe PubMed Central

9 December 2017

Puja Sakhuja

4

1 reference

Europe PubMed Central

9 December 2017

Veena Malhotra

5

1 reference

Europe PubMed Central

9 December 2017

Barjesh C Sharma

6

1 reference

Europe PubMed Central

9 December 2017

Shiv K Sarin

7

1 reference

Europe PubMed Central

9 December 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

9 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

9 December 2017

99

1 reference

Europe PubMed Central

9 December 2017

1946-1952

1 reference

Europe PubMed Central

9 December 2017

10

1 reference

Europe PubMed Central

9 December 2017

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Inhibition of endogenous TNF formation by pentoxifylline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Diagnosis of fatty liver disease: is biopsy necessary?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

The role of cytokines in cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

TNF-alpha and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Pentoxifylline and wellbeing in cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40220.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2004.40220.X

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45077756&oldid=2065292038"